The Trade Desk makes second acquisition
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Dragon Q Energy sends help to power up Malibu
In response to the Los Angeles Wildfires that have ravaged the county, such as the Palisades Fire which has left thousands of homes and businesses destroyed and many more without electricity and internet connectivity, Dragon Q Energy is stepping up to the challenge. The Santa Barbara-based company that specializes in battery technology deployed its PowerPole technology to Read More →
Teledyne finishes fiscal year strong with record Q4
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio closes $80M Series C capital raise
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sonos CEO steps down following app debacle
Consequences of Sonos’ decision to overhaul and release a new version of its app — one that was riddled with bugs and missing key features — came to fruition on Jan. 13 after the company announced it would be looking for a new CEO to start the new year. Sonos, a maker of speakers, headphones Read More →
PBS Biotech secures $17 million in follow-on round
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
A2 Bio closes $80 million Series C financing round
Agoura Hills-based A2 Biotherapeutics, a clinical-stage cell therapy company, on Jan. 9 announced the closing of its $80 million Series C financing round, supported by a syndicate of investors that includes The Column Group and Samsara BioCapital. A2 Bio is developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells. Proceeds Read More →
